Mateo Aboy

LML, University of Cambridge

Principal Research Scholar (PRA)

Trinity Ln

Cambridge, CB2 1TN

United Kingdom

http://https://www.lml.law.cam.ac.uk/people/Research-Scholars-Associates/Prof-mateo-aboy

SCHOLARLY PAPERS

12

DOWNLOADS

977

SSRN CITATIONS

4

CROSSREF CITATIONS

3

Scholarly Papers (12)

1.

COVID-19 Contact Tracing Apps: A Stress Test for Privacy, the GDPR and Data Protection Regimes

Journal of Law and the Biosciences (2020), University of Cambridge Faculty of Law Research Paper No. 23/2020
Number of pages: 21 Posted: 03 Jun 2020
University of Cambridge - Faculty of Law, LML, University of Cambridge and University of Cambridge - Faculty of Law
Downloads 649 (48,739)
Citation 1

Abstract:

Loading...

data privacy, information privacy, GDPR, HIPAA, COVID-19, contact tracing, data protection

2.

The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline

22 Vanderbilt Journal of Entertainment & Technology Law 785, University of Cambridge Faculty of Law Research Paper 33/2019
Number of pages: 53 Posted: 29 May 2019 Last Revised: 21 May 2020
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and LML, University of Cambridge
Downloads 98 (319,086)

Abstract:

Loading...

patent, patentable subject matter, patent eligibility, 35 USC 101, US, Europe, interviews, empirical, comparative

3.

Myriad's Impact on Gene Patents

Nature Biotechnology, Vol. 34, No. 11, p. 1119-1123, Nov. 2016, University of Cambridge Faculty of Law Research Paper No. 58/2017
Number of pages: 8 Posted: 04 Aug 2017 Last Revised: 25 Jun 2019
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 71 (386,870)
Citation 1

Abstract:

Loading...

Patents, BRCA, Myriad, Gene Patents, Patent Publications, Empirical Analysis

4.

Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

European Pharmaceutical Law Review (EPLR), 4(3):153-160
Number of pages: 10 Posted: 28 Jan 2021 Last Revised: 10 Apr 2021
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law and LML, University of Cambridge
Downloads 57 (436,167)

Abstract:

Loading...

GDPR, Data transfer, Schrems II case, data protection, data security, Privacy Shield, Standard Contractual Clauses (SCCs), pharmaceutical sector

5.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 44 (483,463)
Citation 1

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

6.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 18 Sep 2019
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 32 (540,486)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

7.

Continental Drift? Do European Clinical Genetic Testing Laboratories Have a Patent Problem?

European Journal of Human Genetics, 2019, University of Cambridge Faculty of Law Research Paper 32/2019
Number of pages: 12 Posted: 01 Apr 2019 Last Revised: 31 Oct 2019
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, Unversity of Cambidge, King’s College London, Dept of Social Science, Health & Medicine, LML, University of Cambridge, University of Tasmania, European Molecular Genetics Quality Network and University of Sussex
Downloads 26 (575,007)

Abstract:

Loading...

patents, genetic tests, Europe, patent law

8.

Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

9.

One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, University of Cambridge - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

10.

How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?

Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
Posted: 18 Aug 2020
LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

11.

The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Lexxion, 2020
Posted: 14 Aug 2020
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Abstract:

Loading...

12.

Regulatory Responses to Medical Machine Learning

Regulatory responses to medical machine learning. / Minssen, Timo; Gerke, Sara; Aboy, Mateo; Price II, William Nicholson; Cohen, Glenn, 2020, Journal of Law and the Biosciences, Vol. 7, No. 1, 04.2020, p. 1-18. , DOI: 10.1093/jlb/lsaa002
Posted: 14 Aug 2020
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, LML, University of Cambridge, University of Michigan Law School and Harvard Law School

Abstract:

Loading...